Literature DB >> 29970305

An extremely rare case of primary malignancy in giant cell tumor of bone, arising in the right femur and harboring H3F3A mutation.

Yoshitane Tsukamoto1, Hiroyuki Futani2, Takako Kihara3, Takahiro Watanabe3, Shunsuke Kumanishi2, Shohei Matsuo4, Seiichi Hirota3, Takafumi Ueda5, Hidetaka Yamamoto6, Shinichi Yoshiya2.   

Abstract

We experienced a case of primary malignancy in giant cell tumor of bone (GCTB), arising in the right femur and harboring H3F3A mutation. A 27-year-old Japanese male without any prior disease history complained of pain in his right hip joint and right lower limb. Radiological images revealed an osteolytic and multicystic lesion existing mainly at the proximal epiphysis of the right femur. Preoperative clinical diagnosis was GCTB, although irregular marginal sclerosis was an atypical radiographic finding for conventional GCTBs. Biopsy sample from the lesion revealed the coexistence of typical GCTB and undifferentiated high-grade round cell sarcoma. Despite of the wide local resection of the tumor with preoperative and postoperative chemotherapy, the patient died of multiple distant metastases of the tumor 9 months after the surgery. Since heterozygous H3F3A c. 103G>T (p. Gly34Trp) mutation was detected not only in the biopsy sample from the primary site with typical GCTB and high-grade sarcoma components but also in the resected material from the metastatic site with only pure high-grade sarcoma component, the tumor was considered originally derived from conventional GCTB and acquire malignant transformation to high-grade sarcoma. Thus, this is an extremely rare case of primary malignancy in GCTB and the first case report of primary malignancy in GCTB proved the presence of H3F3A mutation even in the sarcoma component.
Copyright © 2018 Elsevier GmbH. All rights reserved.

Entities:  

Keywords:  H3F3A mutation; Primary malignancy in giant cell tumor of bone; Proximal femur; Undifferentiated round cell sarcoma

Mesh:

Substances:

Year:  2018        PMID: 29970305     DOI: 10.1016/j.prp.2018.06.015

Source DB:  PubMed          Journal:  Pathol Res Pract        ISSN: 0344-0338            Impact factor:   3.250


  2 in total

Review 1.  Histone H3.3 mutation in giant cell tumor of bone: an update in pathology.

Authors:  Hidetaka Yamamoto; Shin Ishihara; Yu Toda; Yoshinao Oda
Journal:  Med Mol Morphol       Date:  2019-11-20       Impact factor: 2.309

2.  Malignancy in giant cell tumor of bone in the extremities.

Authors:  Weifeng Liu; Chung Ming Chan; Lihua Gong; Marilyn M Bui; Gang Han; G Douglas Letson; Yongkun Yang; Xiaohui Niu
Journal:  J Bone Oncol       Date:  2020-11-05       Impact factor: 4.072

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.